Quantcast

Latest Oncologists Stories

2014-07-17 23:08:44

Dr. Mark Soloway, who has been appointed Chief of Urologic Oncology at Memorial Cancer Institute, will lead a new division focused on the care of bladder, prostate and kidney cancers, while also establishing a research program. Hollywood, Fla. (PRWEB) July 17, 2014 Mark Soloway, MD, an internationally recognized leader in urologic oncology, has joined the Memorial Cancer Institute and the Memorial Physician Group. Dr. Soloway, who has been appointed Chief of Urologic Oncology, will lead a...

2014-07-11 08:24:23

Company Provides Widest Variety of Actionable Next-Gen Cancer Profiles FT. MYERS, Fla., July 11, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic and molecular testing services, announced today it has launched 23 new and innovative NeoTYPE(TM) Cancer Profiles based on next-generation sequencing (NGS). These new advanced cancer-profiling tools offer oncologists and pathologists a more targeted and comprehensive ability to tailor...

2014-07-07 23:02:25

Allegheny Health Network, Pittsburgh, and Johns Hopkins Medicine today announced that a definitive agreement has been signed by the two organizations that establishes a five-year formal collaboration between Allegheny and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins for research, medical education and clinical services. Pittsburgh, PA (PRWEB) July 07, 2014 Officials at Allegheny Health Network and Johns Hopkins Medicine today announced that a definitive agreement has...

2014-07-01 08:29:44

Former Genentech executive to lead Moderna's first venture company, focused exclusively in novel biology for oncology drug development CAMBRIDGE, Mass., July 1, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Stephen Kelsey, M.D., will become president of Onkaido Therapeutics, Moderna's oncology drug development...

2014-06-27 12:26:51

OWINGS MILLS, Md., June 27, 2014 /PRNewswire-USNewswire/ -- In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of Chesapeake Urology Associates, presented the Urology Care Foundation with a check for $114,248 in support of its prostate cancer research efforts. The funds, which were raised through the Zero Prostate Cancer Challenge (ZPCC) 10K/5K run in September 2013, were presented at the AUA Annual Meeting in Orlando, Florida on May 16, 2014. The...

2014-06-26 08:26:57

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: KOL Insight: Prostate Cancer: Competition intensifies in race to the tophttp://www.reportbuyer.com/pharma_healthcare/diseases/kol_insight_prostate_cancer_competition_intensifies_race_top.html IntroductionThe Prostate Cancer market has seen a number of progressive changes in recent years. The launches of Johnson & Johnson's Zytiga (abiraterone acetate) and Medivation/Astellas's Xtandi...

2014-06-04 20:22:06

The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Research, and Gateway for Cancer Research Award More Than $1.2 Million in Grants MANHATTAN BEACH, Calif., June 4, 2014 /PRNewswire/ -- The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Cancer Research (RTF-CCR) and Gateway for Cancer Research have joined forces to fight one of the deadliest and hardest-to-treat cancers. The strategic collaboration has provided $1 million to facilitate...

2014-06-04 08:30:08

ANN ARBOR, Mich., June 4, 2014 /PRNewswire-USNewswire/ -- A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014 Taubman Prize for Excellence in Translational Medical Science, awarded by the A. Alfred Taubman Medical Research Institute at the University of Michigan Medical School. Carl June, M.D. of the Perelman School of Medicine at the University of Pennsylvania will receive the $100,000 prize in...

2014-06-02 08:30:44

Phase 2 study data presented at the 50th annual meeting of the American Society of Clinical Oncology HORSHAM, Pa., June 2, 2014 /PRNewswire/ -- Abiraterone acetate (ZYTIGA(®)) plus prednisone demonstrated statistically significant reductions in PSA levels at six months, the primary endpoint of the IMAAGEN trial, which evaluates the investigational use of abiraterone acetate plus prednisone (5 mg once daily) in patients with non-metastatic castration-resistant prostate cancer...

2014-06-02 08:30:06

New Chief Medical Officer Brings Wealth of Experience in Innovative Therapies in Oncology SANTA MONICA, Calif., June 2, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced the appointment of David D. Chang, M.D., Ph.D., as Executive Vice President, Research and Development, and Chief Medical Officer. Dr. Chang brings a substantial...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'